'Pill-on-a-thread' cancer screening trial comes to Lancashire - BBC
This story deserves to be shared
Send it to someone who'd care, or post it on your networks.
'I'm happy to be a guinea pig in cancer screening trial'7 hours agoDavid SavilleNorth WestCancer Research UKSenior research nurse Irene Debiram-Beecham is giving patients the procedure from a mobile unitA man who volunteered for a pioneering cancer screening trial has said he's "more than happy to be a guinea pig" if it helps others in the future. Paul Burrows, 70, from Inskip, Fylde, is among people recruited to test a new "pill-on-a-thread" device which researchers hope could pave the way for national screening that could transform the early detection of oesophageal cancer. The trial, backed by Cancer Research UK and the National Institute for Health and Care Research (NIHR), is now being rolled out in Lancashire through mobile screening vans based in Penwortham and Preston. Burrows, who has suffered from heartburn for a decade, said he was keen to take part if it could help future patients. "The pill on the thread sounds fascinating," he said. "I'm more than happy to be a guinea pig and help out in a clinical trial if it will help others in the future.
This article is an excerpt. To read the full content, visit the original source. BBC
Related articles
Four Lancashire areas selected for healthy food funding - BBC
Healthy food projects boosted with £222k fund3 October 2026Rebecca BrahdeNorth WestPA MediaFour local authorities in Lancashire have been selected for funding to improve access to healthy foodFour councils in Lancashire have been selected for government funding to help improve access to healthy and affordable food. The Good Food Neighbourhood Programme, announced by Environment Secretary Angela Eagles at the Labour Party Conference this week, will see £10m invested in the 45 areas in most need. Blackpool, Pendle, Rossendale and Burnley have all been granted £222,000 to invest in community food projects. Blackpool Council's cabinet member for public health, Matthew Thomas, said "food insecurity, health inequality and more limited access to nutritious food are challenges faced by many of our residents". The council said it would build on existing support such as funding free school breakfasts for primary school children, along with support for community-led projects such as food banks and groceries. "These issues can have far-reaching consequences, impacting people's health and wellbeing and life chances so we're pleased to have extra funding in place," Thomas said.
Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress
Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.
Wearing headphones during surgery may reduce nausea and vomiting afterward - Medical Xpress
Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.
Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily
“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.
0 comments
No comments yet. Be the first to share your thoughts!